Results

Found 534 hits.

Search Results for: Quiz 2024 EMC D-PDM-DY-23: Dell PowerProtect Data Manager Deploy 2023 Exam Updated Vce Download 🌋 Copy URL ➥ www.pdfvce.com 🡄 open and search for ⇛ D-PDM-DY-23 ⇚ to download for free 🥇Latest D-PDM-DY-23 Test Testking – Page 40

Treatment of HAE Attacks in the Icatibant Outcome Survey: An Analysis of Icatibant Self-Administration versus Administration by Health Care Professionals

212 Hernández Fernández de Rojas, D.+, Ibáňez, E., Longhurst, H., Maurer, M. Fabien, V., Aberer, W., Bouillet, L., Zanichelli, A., and Caballero, T.: Treatment of HAE attacks in the icatibant outcome survey: an analysis of icatibant self-administration versus administration by health care professionals. Int. Arch. Allergy Immunol. 2015: 167; 21-28. IF: 2.67
more »

Evaluation of patient-reported outcome measures for on-demand treatment of hereditary angioedema attacks and design of KONFIDENT, a phase 3 trial of Sebetralstat

549.

Cohn, D. M.+, Aygören-Pürsün, E., Bernstein, J. A., Farkas, SH., Lumry, W. R., Maurer, M., Zanichelli, A., Iverson, M., Hao, J., Smith, M. D., Yea, C. M., Audhya, P. K., and Riedl, M. A.: Evaluation of patient-reported outcome measures for on-demand treatment of hereditary angioedema attacks and design of KONFIDENT, a phase 3 trial of Sebetralstat. Clin. Transl. Allergy 2023: 23; e12288. IF: 4.60

o.549

more »

Safety and efficacy of Lirentelimab in patients with refractory indolent systemic mastocytosis: a first-in-human clinical trial

551.

Siebenhaar, F., Altrichter, S., Bonnekoh, H., Hawro, T., Hawro, M., Michaelis, E. G., Kantor, A. M., Chang, A. T., Youngblood, B. A., Sing, B., Rasmussen, H. S., and Maurer, M.+: Safety and efficacy of Lirentelimab in patients with refractory indolent systemic mastocytosis: a first-in-human clinical trial. Brit. J. Dermatol. 2023: 189; 511-519. IF: 11.00

o.551

more »